Biozenta Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 6.00 M
as on 16-11-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.63 Cr
as on 16-11-2024
- Satisfied Charges ₹ 3.00 Cr
as on 16-11-2024
- Revenue -40.90%
(FY 2023)
- Profit -94.39%
(FY 2023)
- Ebitda -54.50%
(FY 2023)
- Net Worth 3.87%
(FY 2023)
- Total Assets 41.62%
(FY 2023)
About Biozenta Lifescience
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 6.00 M.
The company currently has active open charges totaling ₹11.63 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Deep Narayan, Jainendra Sahu, Abhishek Jain, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999UR2018PTC008482
- Company No.
008482
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Feb 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biozenta Lifescience Private Limited offer?
Biozenta Lifescience Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Cancer Injection.
Who are the key members and board of directors at Biozenta Lifescience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deep Narayan  | Managing Director | 22-Feb-2018 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jainendra Sahu | Director | 06-May-2024 | Current |
| Abhishek Jain | Director | Current | |
| Babita Saini | Director | Current | |
| Subodh Saini | Director | Current |
Financial Performance of Biozenta Lifescience.
Biozenta Lifescience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 40.9% decrease. The company also saw a substantial fall in profitability, with a 94.39% decrease in profit. The company's net worth moved up by a moderate rise of 3.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biozenta Lifescience?
In 2023, Biozenta Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biozenta Farmacia Private LimitedActive 3 years 6 monthsDeep Narayan and Jainendra Sahu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 19 Nov 2022 | ₹3.40 M | Open |
Sidbi Creation Date: 28 Sep 2022 | ₹3.00 Cr | Open |
Hdfc Bank Limited Creation Date: 09 Nov 2021 | ₹0.40 M | Open |
How Many Employees Work at Biozenta Lifescience?
Biozenta Lifescience has a workforce of 42 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biozenta Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biozenta Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
